Elkhorn Partners’s Biohaven BHVN Stock Holding History

Elkhorn Partners’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.9K	Buy	2,000 +500	+33%	+$5.47K	0.01%	44
2025 Q4	$16.9K	Sell	1,500 -4,400	-75%	-$54.5K	0.01%	43
2025 Q3	$88.6K	Buy	5,900 +100	+2%	+$1.46K	0.06%	25
2025 Q2	$81.8K	Buy	5,800 +1,200	+26%	+$21.4K	0.06%	29
2025 Q1	$111K	Buy	4,600 +1,300	+39%	+$45.8K	0.07%	23
2024 Q4	$123K	Buy	3,300 +1,100	+50%	+$51.3K	0.08%	24
2024 Q3	$110K	Sell	2,200 -1,400	-39%	-$54.5K	0.07%	29
2024 Q2	$125K	Buy	+3,600	New	+$142K	0.09%	27
2022 Q4	–	Sell	-102	Closed	-$15K	–	42
2022 Q3	$15K	Buy	+102	New	+$740	0.01%	41

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Elkhorn Partners's BHVN Position: Q1 2026 in Review

Elkhorn Partners increased its Biohaven (BHVN) stake by 33% in Q1 2026, buying an estimated $5.47K and bringing the position to 2,000 shares worth $16.9K. The position accounts for 0.01% of the portfolio, ranked #44.

Elkhorn Partners first reported a position in BHVN in Q3 2022 and has held it in 9 quarters since. The position peaked at $125K in Q2 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Elkhorn Partners held 2,000 shares of Biohaven worth $16.9K as of Q1 2026.
Elkhorn Partners bought 500 Biohaven shares in Q1 2026, an estimated $5.47K.
Biohaven made up 0.01% of Elkhorn Partners's portfolio in Q1 2026, its #44 holding.
Elkhorn Partners first reported a position in Biohaven in Q3 2022 and has held it in 9 quarters since.
Elkhorn Partners's Biohaven position peaked at $125K in Q2 2024.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Elkhorn Partners's 13F filing for Q1 2026, filed 14 May 2026.